Lynx1 Capital Management »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $206k 8.2k 24.99
2024-06-30 $177k 9.5k 18.67

More positions owned by Lynx1 Capital Management

Merus N V (MRUS)
Stoke Therapeutics (STOK)
C4 Therapeutics Com Stk (CCCC)
Gh Research Ordinary Shares (GHRS)
Tscan Therapeutics (TCRX)
Allogene Therapeutics (ALLO)
Cullinan Oncology (CGEM)
Passage Bio (PASG)
Ibio Con New (IBIO)
Caribou Biosciences (CRBU)
Kodiak Sciences (KOD)
Pieris Pharmaceuticals Com New (PIRS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bionomics Ads (BNOX)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)

View all positions for Lynx1 Capital Management

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
BlackRock
Fairmount Funds Management
Braidwell
Baker Bros. Advisors
Rubric Capital Management
Morgan Stanley
Hillhouse Capital Advisors
State Street Corporation
Pictet Asset Management Holding SA
Nuveen Asset Management
Dimensional Fund Advisors
Driehaus Capital Management
Rice Hall James & Associates
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A